主要研究方向：神经药理

主要研究领域：阿尔茨海默病

(1) 2020-09至现在, 上海交通大学, 基础医学院, 博士在读

(2) 2020-01至现在, 437必赢会员中心, 437必赢会员中心, 实验师

(3) 2019-07至2019-12, 437必赢会员中心, 437必赢会员中心, 助理实验师

(4) 2017-07至2019-06, 437必赢会员中心, 基础药理教育部重点实验室暨特色民族药教育部国际合作联合实验室, 助理实验师

(5) 2014-09至2017-06, 遵义医学院, 基础药理教育部重点实验室暨特色民族药教育部国际合作联合实验室，药理学硕士

(6) 2010-09至2014-06, 遵义医学院, 药学院, 学士

(1)HuangJuan^#;HuangNanqu^#;Xu Shangfu; Luo Yong; Li Yan; Jin Hai; Yu Changyin; Shi Jingshan; FengJin*; Signaling mechanisms underlying inhibition of neuroinflammation by resveratrol in neurodegenerative diseases,The Journal of Nutritional Biochemistry, 2021, 88: 108552.

(2)HuangJuan^#;HuangNanqu^#;Zhang Minghui;Nie Jing; Xu Yunyan; Wu Qin; Shi Jingshan*; Dendrobium alkaloids decrease Aβ by regulating alpha- and beta-secretases in hippocampal neurons of SD rats,PeerJ, 2019, 7: e7627.

(3)HuangJuan^#; Yu Jialong^#; Tu Lin; Huang Nanqu; Li Hang; Luo Yong* Isocitrate Dehydrogenase Mutations in Glioma: From Basic Discovery to Therapeutics Development,Frontiers in Oncology, 2019(506).

(4) Song Huiwen^#; Feng Xing^#; Zhang Hen^#g; Luo Yunmei;Huang Juan; Lin Meihua; Jin Junfei; Ding Xue; Wu Shujing; Huang He; Yu Tian; Zhang Mukun; Hong Haiou; Yao Shihua*; Zhao Yongxiang*; Zhang Zhiyong*; METTL3 and ALKBH5 oppositely regulate m(6)A modification of TFEB mRNA, which dictates the fate of hypoxia/reoxygenation-treated cardiomyocytes: hypoxia/reoxygenation- treated cardiomyocytes,Autophagy, 2019, 15(8): 1419-1437.

（5）黄娟；杨小惠；柳源；吴芹；石京山,β-淀粉样蛋白前体蛋白裂解酶1相关干预策略在阿尔采末病治疗的研究进展,中国新药与临床杂志,2017,7:373-379.

国家自然科学基金委员会,地区项目, 82060728,金钗石斛总生物碱调控PI3K/Akt/GSK-3β通路抑制Tau蛋白过度磷酸化在AD中的机制研究, 2021-01至2024-12, 34万元,在研,主持